IL-17A and IL-17F orchestrate macrophages to promote lung cancer

Purpose: Previously, inflammation has been found to be associated with the development of lung Cancer. Despite their well-characterized pro-inflammatory functions, the putative roles of interleukin-17 (IL-17) cytokine family members in tumorigenesis have remained controversial. While IL-17A exhibits both pro- and anti-tumor effects, IL-17F has been suggested to serve as a candidate for Cancer therapy. Thus, we aimed at clarifying the involvement of IL-17A/F in lung Cancer.

Methods: IL-17 Receptor expression in human and murine lung Cancer cells was assessed using immunofluorescence. The effect of IL-17A/F stimulation on lung Cancer cell viability (SRB assay) and metabolism (glucose consumption and lactate production) was evaluated under normoxic and hypoxic conditions. Characterization of IL-17A/F-stimulated macrophages was performed by flow cytometry and ELISA. The effect of conditioned media (CM) from IL-17A/F-stimulated macrophages was evaluated on lung Cancer cell migration. The effect of CM-stimulated macrophages on lung tumor growth, proliferation and angiogenesis was evaluated in vivo using a chicken chorioallantoic membrane (CAM) assay.

Results: No alterations in lung Cancer cell viability or metabolism were observed upon direct stimulation with IL-17A/F. We found, however, that CM from IL-17A/F-stimulated macrophages promoted both murine and human lung Cancer cell progression through an increased migration capacity in vitro and enhanced in vivo tumor growth, proliferation and angiogenesis. These findings were supported by an increased polarization of human macrophages towards a M2-like phenotype.

Conclusions: Our data indicate that IL-17A/F act through immune cell orchestration, i.e., of macrophages, to promote lung Cancer cell growth and progression. In addition, our data provide a link between IL-17A/F activity and lung Cancer cell-macrophage crosstalk.

IL-17A; IL-17F; Lung cancer; Macrophages; Tumor microenvironment.